Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review
Senefeld, J.; Klassen, S. A.; Ford, S. K.; Wiggins, C. C.; Bostrom, B. C.; Thompson, M. A.; Baker, S. E.; Nicholson, W. T.; Johnson, P. W.; Carter, R. E.; Henderson, J. P.; Hartman, W. R.; Pirofski, L.-a.; Wright, R. S.; Fairweather, D.; Bruno, K. A.; Paneth, N. S.; Casadevall, A.; Joyner, M. J.
Show abstract
0In the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2 including among patients with innate or acquired immunodeficiency. However, the association between COVID-19-associated mortality in patients with immunodeficiency and therapeutic use of convalescent plasma is unknown. We review clinical features and treatment protocols of COVID-19 patients with immunodeficiency after treatment with human convalescent plasma. We also discuss the time course and clinical features of recovery. These insights provide evidence for the need to develop a clear treatment protocol for COVID-19 patients with immunodeficiency and support the efficacy of convalescent plasma in patients with primary or secondary immunodeficiency.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring the role of Large Language Models (LLMs) in hematology: a systematic review of applications, benefits, and limitations 92%
- Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents 90%
- Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19) 90%
Similar papers in this journal
- Patient ABO blood type is a major predictor of a positive DAT following a transfusion reaction 92%
- Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations 92%
- The Local Initiative For Emergency Blood (LIFE-Blood) Study: A mixed-methods, single center exploration of civilian walking blood bank need, feasibility, and safety in a low-resource blood desert 91%
Similar papers in this journal
- Mitigation of gastrointestinal graft versus host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination 89%
- Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial 89%
- Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment 88%
Similar papers in this journal
- Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection 94%
- Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders 94%
- COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials 92%
Similar papers in this journal
- High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern 94%
- Donor Bone Marrow Derived Macrophage Engraftment into the Central Nervous System of Allogeneic Transplant Patients 91%
- Using Whole Genome Sequencing to Characterize Clinically Significant Blood Groups Among Healthy Older Australians 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.